产品说明
一般描述
Rivastigmine Related Compound E is an impurity of rivastigmine, a novel acetylcholine esterase inhibitor. It is mainly used for the treatment of Alzheimer′s disease.
应用
These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.
Rivastigmine may be used as a pharmaceutical reference standard for the quantification of the analyte in pharmaceutical formulations using electroanalytical technique and high-performance thin layer chromatography method.
分析说明
These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
其他说明
This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
附注
To see an example of a Certificate of Analysis for this material enter LRAB4763 in the Documents slot below. This is an example certificate only and may not be the lot that you receive.
基本信息
| 经验(实验)分子式 | C15H25IN2O2 |
| 分子量 | 392.28 |
| NACRES | NA.24 |
产品性质
| 质量水平 | 300 |
| 等级 | certified reference material pharmaceutical secondary standard |
| CofA | current certificate can be downloaded |
| 包装 | pkg of 30 mg |
| 格式 | neat |
| 药典可追溯性 | traceable to USP 1604950 |
| 储存温度 | -10 to -25℃ |
安全信息
| 象形图 |  |
| 警示用语： | Danger |
| 危险声明 | H300 + H310 + H330 |
| 预防措施声明 | P260 - P262 - P280 - P301 + P310 + P330 - P302 + P352 + P310 - P304 + P340 + P310 - P403 + P233 |
| 危险分类 | Acute Tox. 2 Dermal - Acute Tox. 2 Inhalation - Acute Tox. 2 Oral |
| 储存分类代码 | 6.1B - Non-combustible, acute toxic Cat. 1 and 2 / very toxic hazardous materials |
| WGK | WGK 3 |
| 闪点(F) | Not applicable |
| 闪点(C) | Not applicable |
